Victory Capital Management Inc Eq Rx, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$1.66 - $2.31 $9,838 - $13,691	5,927 Added 21.73%	33,202 $73,000
Q2 2023 Jul 27, 2023	SELL	$1.61 - $1.96 $1,022 - $1,244	-635 Reduced 2.28%	27,275 $50,000
Q1 2023 May 02, 2023	BUY	$1.8 - $2.83 $3,340 - $5,252	1,856 Added 7.12%	27,910 $54,000
Q4 2022 Feb 09, 2023	BUY	$2.05 - $5.5 $9,600 - $25,756	4,683 Added 21.91%	26,054 $64,000
Q3 2022 Nov 02, 2022	SELL	$0.94 - $5.99 $20,487 - $130,552	-21,795 Reduced 50.49%	21,371 $106,000
Q2 2022 Aug 01, 2022	SELL	$3.2 - $5.69 $905 - $1,610	-283 Reduced 0.65%	43,166 $202,000
Q1 2022 May 04, 2022	BUY	$2.8 - $7.39 $121,657 - $321,088	43,449 New	43,449 $226,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.